Literature DB >> 28348037

What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Consideration of Strategies to Improve the Value of Animal Models.

Ramin Sedaghat Herati1,2, E John Wherry2,3.   

Abstract

Animal models are an essential feature of the vaccine design toolkit. Although animal models have been invaluable in delineating the mechanisms of immune function, their precision in predicting how well specific vaccines work in humans is often suboptimal. There are, of course, many obvious species differences that may limit animal models from predicting all details of how a vaccine works in humans. However, careful consideration of which animal models may have limitations should also allow more accurate interpretations of animal model data and more accurate predictions of what is to be expected in clinical trials. In this article, we examine some of the considerations that might be relevant to cross-species extrapolation of vaccine-related immune responses for the prediction of how vaccines will perform in humans.
Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28348037      PMCID: PMC5880169          DOI: 10.1101/cshperspect.a031583

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  41 in total

Review 1.  Immune responses to rotavirus infection and vaccination and associated correlates of protection.

Authors:  Ulrich Desselberger; Hans-Iko Huppertz
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

Review 2.  Sex differences in immune responses.

Authors:  Sabra L Klein; Katie L Flanagan
Journal:  Nat Rev Immunol       Date:  2016-08-22       Impact factor: 53.106

3.  Sequential Infection with Common Pathogens Promotes Human-like Immune Gene Expression and Altered Vaccine Response.

Authors:  Tiffany A Reese; Kevin Bi; Amal Kambal; Ali Filali-Mouhim; Lalit K Beura; Matheus C Bürger; Bali Pulendran; Rafick-Pierre Sekaly; Stephen C Jameson; David Masopust; W Nicholas Haining; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2016-04-20       Impact factor: 21.023

4.  Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.

Authors:  R B Ren; F Costantini; E J Gorgacz; J J Lee; V R Racaniello
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

5.  Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

Authors:  Susan P Buchbinder; Devan V Mehrotra; Ann Duerr; Daniel W Fitzgerald; Robin Mogg; David Li; Peter B Gilbert; Javier R Lama; Michael Marmor; Carlos Del Rio; M Juliana McElrath; Danilo R Casimiro; Keith M Gottesdiener; Jeffrey A Chodakewitz; Lawrence Corey; Michael N Robertson
Journal:  Lancet       Date:  2008-11-13       Impact factor: 79.321

Review 6.  Effect of helminth-induced immunity on infections with microbial pathogens.

Authors:  Padmini Salgame; George S Yap; William C Gause
Journal:  Nat Immunol       Date:  2013-11       Impact factor: 25.606

7.  Herpesvirus latency confers symbiotic protection from bacterial infection.

Authors:  Erik S Barton; Douglas W White; Jason S Cathelyn; Kelly A Brett-McClellan; Michael Engle; Michael S Diamond; Virginia L Miller; Herbert W Virgin
Journal:  Nature       Date:  2007-05-17       Impact factor: 49.962

8.  Bystander chronic infection negatively impacts development of CD8(+) T cell memory.

Authors:  Erietta Stelekati; Haina Shin; Travis A Doering; Douglas V Dolfi; Carly G Ziegler; Daniel P Beiting; Lucas Dawson; Jennifer Liboon; David Wolski; Mohammed-Alkhatim A Ali; Peter D Katsikis; Hao Shen; David S Roos; W Nicholas Haining; Georg M Lauer; E John Wherry
Journal:  Immunity       Date:  2014-05-15       Impact factor: 31.745

9.  Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain.

Authors:  Masaya Fukushi; Tateki Ito; Teruaki Oka; Toshio Kitazawa; Tohru Miyoshi-Akiyama; Teruo Kirikae; Makoto Yamashita; Koichiro Kudo
Journal:  PLoS One       Date:  2011-06-20       Impact factor: 3.240

Review 10.  A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data.

Authors:  Helen McShane; Ann Williams
Journal:  Tuberculosis (Edinb)       Date:  2013-12-01       Impact factor: 3.131

View more
  13 in total

1.  The Promises of Speeding Up: Changes in Requirements for Animal Studies and Alternatives during COVID-19 Vaccine Approval-A Case Study.

Authors:  Merel Ritskes-Hoitinga; Yari Barella; Tineke Kleinhout-Vliek
Journal:  Animals (Basel)       Date:  2022-07-05       Impact factor: 3.231

2.  Multiepitope Fusion Antigen: MEFA, an Epitope- and Structure-Based Vaccinology Platform for Multivalent Vaccine Development.

Authors:  Siqi Li; Kuo Hao Lee; Weiping Zhang
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates.

Authors:  Labanya Mukhopadhyay; Pragya D Yadav; Nivedita Gupta; Sreelekshmy Mohandas; Deepak Y Patil; Anita Shete-Aich; Samiran Panda; Balram Bhargava
Journal:  Indian J Med Res       Date:  2021 Jan & Feb       Impact factor: 2.375

4.  Towards COVID-19 Prophylaxis: An AIDS Preclinical Research Perspective.

Authors:  Michele Di Mascio
Journal:  Cancer Stud Ther       Date:  2020-07-19

5.  Improving natural product research translation: From source to clinical trial.

Authors:  Barbara C Sorkin; Adam J Kuszak; Gregory Bloss; Naomi K Fukagawa; Freddie Ann Hoffman; Mahtab Jafari; Bruce Barrett; Paula N Brown; Frederic D Bushman; Steven J Casper; Floyd H Chilton; Christopher S Coffey; Mario G Ferruzzi; D Craig Hopp; Mairead Kiely; Daniel Lakens; John B MacMillan; David O Meltzer; Marco Pahor; Jeffrey Paul; Kathleen Pritchett-Corning; Sara K Quinney; Barbara Rehermann; Kenneth D R Setchell; Nisha S Sipes; Jacqueline M Stephens; D Lansing Taylor; Hervé Tiriac; Michael A Walters; Dan Xi; Giovanna Zappalá; Guido F Pauli
Journal:  FASEB J       Date:  2019-12-10       Impact factor: 5.834

Review 6.  How many animals are used for SARS-CoV-2 research?: An overview on animal experimentation in pre-clinical and basic research.

Authors:  Philipp Schwedhelm; Johanna Kusnick; Céline Heinl; Gilbert Schönfelder; Bettina Bert
Journal:  EMBO Rep       Date:  2021-09-07       Impact factor: 8.807

Review 7.  Designing spatial and temporal control of vaccine responses.

Authors:  Gillie A Roth; Vittoria C T M Picece; Ben S Ou; Wei Luo; Bali Pulendran; Eric A Appel
Journal:  Nat Rev Mater       Date:  2021-09-28       Impact factor: 76.679

Review 8.  Human lung-on-chips: Advanced systems for respiratory virus models and assessment of immune response.

Authors:  Ecem Saygili; Ece Yildiz-Ozturk; Macauley J Green; Amir M Ghaemmaghami; Ozlem Yesil-Celiktas
Journal:  Biomicrofluidics       Date:  2021-03-23       Impact factor: 2.800

Review 9.  Is it Time for Reviewer 3 to Request Human Organ Chip Experiments Instead of Animal Validation Studies?

Authors:  Donald E Ingber
Journal:  Adv Sci (Weinh)       Date:  2020-10-12       Impact factor: 16.806

Review 10.  Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems.

Authors:  Benjamin O Murray; Carlos Flores; Corin Williams; Deborah A Flusberg; Elizabeth E Marr; Karolina M Kwiatkowska; Joseph L Charest; Brett C Isenberg; Jennifer L Rohn
Journal:  Front Cell Infect Microbiol       Date:  2021-05-26       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.